Parent Directory | - | - |
12px-PD-icon.svg.png | Mar 6, 2023, 9:09:42 AM | 487 bytes |
18px-PD-icon.svg.png | Mar 6, 2023, 9:09:42 AM | 663 bytes |
7px-Yes_check.svg.png | Mar 6, 2023, 9:09:42 AM | 841 bytes |
24px-PD-icon.svg.png | Mar 6, 2023, 9:09:42 AM | 843 bytes |
11px-Yes_check.svg.png | Mar 6, 2023, 9:09:42 AM | 1,035 bytes |
14px-Yes_check.svg.png | Mar 6, 2023, 9:09:42 AM | 1,197 bytes |
150px-Bullous_pemphigoid_induced_by_pembrolizumab_(DermNet_NZ_pembrolizumab-pemphigoid-01).jpg | Mar 6, 2023, 9:09:42 AM | 6,006 bytes |
250px-Bullous_pemphigoid_induced_by_pembrolizumab_(DermNet_NZ_pembrolizumab-pemphigoid-03).jpg | Mar 6, 2023, 9:09:42 AM | 7,546 bytes |
250px-Dermatitis_induced_by_pembrolizumab_(DermNet_NZ_pembrolizumab-eczema-06).jpg | Mar 6, 2023, 9:09:42 AM | 8,278 bytes |
250px-Bullous_pemphigoid_induced_by_pembrolizumab_(DermNet_NZ_pembrolizumab-pemphigoid-02).jpg | Mar 6, 2023, 9:09:42 AM | 9,829 bytes |
225px-Bullous_pemphigoid_induced_by_pembrolizumab_(DermNet_NZ_pembrolizumab-pemphigoid-01).jpg | Mar 6, 2023, 9:09:42 AM | 11,560 bytes |
375px-Bullous_pemphigoid_induced_by_pembrolizumab_(DermNet_NZ_pembrolizumab-pemphigoid-03).jpg | Mar 6, 2023, 9:09:42 AM | 14,932 bytes |
375px-Dermatitis_induced_by_pembrolizumab_(DermNet_NZ_pembrolizumab-eczema-06).jpg | Mar 6, 2023, 9:09:42 AM | 16,554 bytes |
300px-Bullous_pemphigoid_induced_by_pembrolizumab_(DermNet_NZ_pembrolizumab-pemphigoid-01).jpg | Mar 6, 2023, 9:09:42 AM | 19,415 bytes |
375px-Bullous_pemphigoid_induced_by_pembrolizumab_(DermNet_NZ_pembrolizumab-pemphigoid-02).jpg | Mar 6, 2023, 9:09:42 AM | 21,818 bytes |
500px-Bullous_pemphigoid_induced_by_pembrolizumab_(DermNet_NZ_pembrolizumab-pemphigoid-03).jpg | Mar 6, 2023, 9:09:42 AM | 24,422 bytes |
500px-Dermatitis_induced_by_pembrolizumab_(DermNet_NZ_pembrolizumab-eczema-06).jpg | Mar 6, 2023, 9:09:42 AM | 26,226 bytes |
500px-Bullous_pemphigoid_induced_by_pembrolizumab_(DermNet_NZ_pembrolizumab-pemphigoid-02).jpg | Mar 6, 2023, 9:09:42 AM | 38,134 bytes |
220px-PD-L1_positive_lung_adenocarcinoma_--_intermed_mag.jpg | Mar 6, 2023, 9:09:42 AM | 47,644 bytes |
300px-Pembrolizumab_5DK3.png | Mar 6, 2023, 9:09:42 AM | 90,806 bytes |
330px-PD-L1_positive_lung_adenocarcinoma_--_intermed_mag.jpg | Mar 6, 2023, 9:09:42 AM | 100,644 bytes |
440px-PD-L1_positive_lung_adenocarcinoma_--_intermed_mag.jpg | Mar 6, 2023, 9:09:42 AM | 164,740 bytes |
450px-Pembrolizumab_5DK3.png | Mar 6, 2023, 9:09:42 AM | 176,918 bytes |
600px-Pembrolizumab_5DK3.png | Mar 6, 2023, 9:09:42 AM | 279,609 bytes |